General Information of the Compound
Compound ID
CP0575340
Compound Name
1-benzyl-5-ethyl-N-(oxolan-3-ylmethyl)benzimidazol-2-amine
    Show/Hide
Structure
Formula
C21H25N3O
Molecular Weight
335.451
Canonical SMILES
CCc1ccc2n(Cc3ccccc3)c(NCC3CCOC3)nc2c1
    Show/Hide
InChI
InChI=1S/C21H25N3O/c1-2-16-8-9-20-19(12-16)23-21(22-13-18-10-11-25-15-18)24(20)14-17-6-4-3-5-7-17/h3-9,12,18H,2,10-11,13-15H2,1H3,(H,22,23)
    Show/Hide
InChIKey
KIIKCEVUAHKQHI-UHFFFAOYSA-N
Physicochemical Property
logP
4.0954
Rotatable Bonds
6
Heavy Atom Count
25
Polar Areas
39.08
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
4
Complexity
25

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 168287488
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT05452, Short transient receptor potential channel 5
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
IC50 = 2270 nM
   TI
   LI
   LO
   TS